Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYFrontiers in cardiovascular medicine

Incremental value of dedicated [201Tl] cadmium-zinc-telluride thallium SPECT over rest/stress [99mTc] technetium sestamibi SPECT MPI: a comparative analysis of fixed perfusion defects

  1. 1Faculty of Medicine, Khon Kaen University , ,
  2. 2Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Khon Kaen University , ,

Abstract

Background: Rest/stress [ 99m Tc]technetium sestamibi single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is a mainstay for evaluating coronary artery disease. However, fixed defects on standard MPI present a well-documented clinical challenge, as they can represent either non-viable scars or viable hibernating myocardium. We aimed to examine the incremental value and rate of diagnostic reclassification provided by performing subsequent dedicated cadmium-zinc-telluride (CZT) [ ²⁰¹ Tl]thallium myocardial SPECT in patients presenting with fixed defects on standard sestamibi MPI.

Methods: In this retrospective study, we analyzed 174 patients—totaling 2,958 myocardial segments—who underwent both protocols. Intermodality correlation was assessed, and the rates of segmental and patient-level reclassification (segments converting from <50% maximum uptake on sestamibi to ≥50% maximum uptake on thallium) were quantified.

Results: While a moderately high correlation was observed between the baseline uptake scores of the two modalities (Spearman's r = 0.817 for rest sestamibi vs. thallium), thallium imaging provided substantial additional information, with 48.0% of segments classified as fixed defects on sestamibi SPECT demonstrating improved uptake on thallium SPECT. At the patient level, 78.9% of individuals who had fixed defects on the initial sestamibi SPECT had at least one segment reclassified. Receiver operating characteristic analysis showed that a rest sestamibi uptake score of <20% predicted a lack of reclassification with 99% specificity, although with low sensitivity (12%).

Conclusion: In a selected cohort of patients presenting with fixed defects on standard rest/stress sestamibi SPECT MPI, supplementary imaging with thallium myocardial CZT SPECT provided incremental data, altering the clinical interpretation in nearly 80% of patients. However, in the absence of an independent viability reference standard, this finding represents intertracer diagnostic reclassification rather than proven functional recovery. A rest sestamibi uptake of <20% demonstrated high specificity for non-reclassification; however, this cutoff should be interpreted cautiously as a potential gatekeeping finding when considering downstream testing rather than a rigid rule for omitting further myocardial viability evaluation.

Related

  1. Cautious clinical interpretation of preoperative Tc-99m-Sestamibi localization scan among chronic kidney disease and transplanted patients
    Orel Elhadad, Ran Fisher, Keren Tzukert +3
    Surgery in practice and sciencePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Diagnostic Concordance of Immediate Versus 1-Hour Technetium-99m Hydroxymethylene Diphosphonate Scintigraphy in Suspected Transthyretin Amyloid Cardiomyopathy
    A. Costa, A. Suits, J. Miller +9
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
  3. Opportunistic computed tomography to identify osteoporosis in primary hyperparathyroidism using sestamibi SPECT/CT scans
    Gary Ka Wai Chan, Xi Xiong, Yan Ho Hui +2
    Journal of the Endocrine SocietyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  4. Segment-Level Evaluability of Dedicated Non-ECG-Gated Coronary CT Angiography: Associations with Calcification, Heart Rate, Vessel Territory, and Caliber
    Kun Wang, Aiyun Sun, Xia Qiu +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Introduction to Your Rights and Care Standards: Dedicated Guides for Type 1 and Type 2 Diabetes
    Joan Bardsley, Joan Bardsley, Jo-Anne Rizzotto +10
    Diabetes, Obesity, and Cardiometabolic CAREPeer-reviewedPublisher termsFull textEndocrinology & metabolismPMC
BibTeX
@article{teungsang2026incremental,
  title = {{Incremental value of dedicated [201Tl] cadmium-zinc-telluride thallium SPECT over rest/stress [99mTc] technetium sestamibi SPECT MPI: a comparative analysis of fixed perfusion defects}},
  author = {Phattaraphorn Teungsang and Methawee Laohamethanee and Napat Kitkhuandee and Thanapol Kliteneam and Daris Theerakulpisut},
  journal = {Frontiers in cardiovascular medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1901315},
  url = {https://europepmc.org/article/PMC/PMC13672228},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Incremental value of dedicated [201Tl] cadmium-zinc-telluride thallium SPECT over rest/stress [99mTc] technetium sestamibi SPECT MPI: a comparative analysis of fixed perfusion defects
AU  - Phattaraphorn Teungsang
AU  - Methawee Laohamethanee
AU  - Napat Kitkhuandee
AU  - Thanapol Kliteneam
AU  - Daris Theerakulpisut
PY  - 2026
DA  - 2026/10/02
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1901315
UR  - https://europepmc.org/article/PMC/PMC13672228
AB  - Background: Rest/stress [ 99m Tc]technetium sestamibi single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is a mainstay for evaluating coronary artery disease. However, fixed defects on standard MPI present a well-documented clinical challenge, as they can represent either non-viable scars or viable hibernating myocardium. We aimed to examine the incremental value and rate of diagnostic reclassification provided by performing subsequent dedicated cadmium-zinc-telluride (CZT) [ ²⁰¹ Tl]thallium myocardial SPECT in patients presenting with fixed defects on standard sestamibi MPI.  Methods: In this retrospective study, we analyzed 174 patients—totaling 2,958 myocardial segments—who underwent both protocols. Intermodality correlation was assessed, and the rates of segmental and patient-level reclassification (segments converting from <50% maximum uptake on sestamibi to ≥50% maximum uptake on thallium) were quantified.  Results: While a moderately high correlation was observed between the baseline uptake scores of the two modalities (Spearman's r = 0.817 for rest sestamibi vs. thallium), thallium imaging provided substantial additional information, with 48.0% of segments classified as fixed defects on sestamibi SPECT demonstrating improved uptake on thallium SPECT. At the patient level, 78.9% of individuals who had fixed defects on the initial sestamibi SPECT had at least one segment reclassified. Receiver operating characteristic analysis showed that a rest sestamibi uptake score of <20% predicted a lack of reclassification with 99% specificity, although with low sensitivity (12%).  Conclusion: In a selected cohort of patients presenting with fixed defects on standard rest/stress sestamibi SPECT MPI, supplementary imaging with thallium myocardial CZT SPECT provided incremental data, altering the clinical interpretation in nearly 80% of patients. However, in the absence of an independent viability reference standard, this finding represents intertracer diagnostic reclassification rather than proven functional recovery. A rest sestamibi uptake of <20% demonstrated high specificity for non-reclassification; however, this cutoff should be interpreted cautiously as a potential gatekeeping finding when considering downstream testing rather than a rigid rule for omitting further myocardial viability evaluation.
SN  - 2297-055X
ER  -